Form 4: AtriCure COO Acquires Shares Under ESPP
Insider Transaction Report
AtriCure, Inc. reports that Chief Operating Officer Douglas J. Seith acquired 527 shares of common stock through the company's Employee Stock Purchase Plan.
Summary
- Douglas J. Seith, Chief Operating Officer of AtriCure, Inc., acquired 527 shares of common stock.
- The acquisition occurred on June 30, 2026, under the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP).
- The shares were purchased at a discounted price of $23.78 per share, representing 85% of the closing price on the acquisition date.
- The closing price of AtriCure's common stock on June 30, 2026, was $27.98.
- Following this transaction, Mr. Seith beneficially owns 229,867 shares of common stock.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents an insider acquiring shares, which can signal confidence, but it is a routine transaction under an established plan.
Positives
- Insider acquisition of company stock, indicating confidence from a key executive.
- Acquisition made through an Employee Stock Purchase Plan, suggesting a structured and ongoing investment by the executive.
- Shares acquired at a discount, providing a financial benefit to the reporting person.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider purchases, especially through employee stock purchase plans, can be viewed positively by the market as they often reflect a belief in the company's long-term prospects by those closest to its operations.
Stakeholder Impact
- Shareholders: May view the insider purchase as a positive signal of management's confidence in the company's future performance.
- Employees: The Employee Stock Purchase Plan provides an opportunity for employees to invest in the company at a favorable price.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Transaction Date for acquisition of common stock under ESPP and last trading day of the applicable offering period. |
| 07/02/2026 | Date of signature for the filing. |
Recommendation
holdThis filing represents a routine insider purchase under an Employee Stock Purchase Plan, which is generally not a strong indicator for a significant shift in investment strategy. It confirms ongoing participation by a key executive but does not provide new strategic or financial information that would warrant a change from a 'hold' position.
Keywords
AtriCure, ATRC, Form 4, Insider Trading, Employee Stock Purchase Plan, Stock Acquisition, Douglas J. Seith, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.